Lifestyle Intervention Before Infertility Treatment No Benefit

Share this content:
Lifestyle Intervention Before Infertility Treatment No Benefit
Lifestyle Intervention Before Infertility Treatment No Benefit

FRIDAY, May 20, 2016 (HealthDay News) -- A lifestyle intervention preceding infertility treatment does not result in higher rates of vaginal birth among obese infertile women, according to a study published in the May 19 issue of the New England Journal of Medicine.

Meike A.Q. Mutsaerts, M.D., Ph.D., from the University of Groningen in the Netherlands, and colleagues randomized infertile women with a body mass index of 29 kg/m² or more to a six-month lifestyle intervention preceding 18 months of infertility treatment (289 women) or to a control group with immediate infertility treatment for 24 months (285 women).

The researchers found that the intervention group had a discontinuation rate of 21.8 percent. The mean weight loss was 4.4 kg and 1.1 kg in the intervention group and control groups, respectively, in intention-to-treat analyses (P < 0.001). The primary outcome of vaginal birth of a healthy singleton at term within 24 months occurred in 27.1 and 35.2 percent of the intervention and control groups, respectively (rate ratio in the intervention group, 0.77; 95 percent confidence interval, 0.60 to 0.99).

"In obese infertile women, a lifestyle intervention preceding infertility treatment, as compared with prompt infertility treatment, did not result in higher rates of a vaginal birth of a healthy singleton at term within 24 months after randomization," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »